A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"Hashtag": "as:Hashtag"
}
],
"id": "https://toot.community/users/CRISPR_News/statuses/111776001107602994",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2024-01-18T08:27:03Z",
"url": "https://toot.community/@CRISPR_News/111776001107602994",
"attributedTo": "https://toot.community/users/CRISPR_News",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://toot.community/users/CRISPR_News/followers"
],
"sensitive": false,
"atomUri": "https://toot.community/users/CRISPR_News/statuses/111776001107602994",
"inReplyToAtomUri": null,
"conversation": "tag:toot.community,2024-01-18:objectId=115667426:objectType=Conversation",
"content": "<p>🧬 FDA approves CRISPR-based Casgevy for beta thalassemia, expanding gene therapy options beyond sickle cell disease. A step forward in precision medicine! <a href=\"https://toot.community/tags/CRISPR\" class=\"mention hashtag\" rel=\"tag\">#<span>CRISPR</span></a> <a href=\"https://toot.community/tags/GeneTherapy\" class=\"mention hashtag\" rel=\"tag\">#<span>GeneTherapy</span></a> <a href=\"https://toot.community/tags/HealthcareInnovation\" class=\"mention hashtag\" rel=\"tag\">#<span>HealthcareInnovation</span></a> 🩸🔬🧪<a href=\"https://www.axios.com/2024/01/17/crispr-therapy-fda-expands\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">axios.com/2024/01/17/crispr-th</span><span class=\"invisible\">erapy-fda-expands</span></a></p>",
"contentMap": {
"en": "<p>🧬 FDA approves CRISPR-based Casgevy for beta thalassemia, expanding gene therapy options beyond sickle cell disease. A step forward in precision medicine! <a href=\"https://toot.community/tags/CRISPR\" class=\"mention hashtag\" rel=\"tag\">#<span>CRISPR</span></a> <a href=\"https://toot.community/tags/GeneTherapy\" class=\"mention hashtag\" rel=\"tag\">#<span>GeneTherapy</span></a> <a href=\"https://toot.community/tags/HealthcareInnovation\" class=\"mention hashtag\" rel=\"tag\">#<span>HealthcareInnovation</span></a> 🩸🔬🧪<a href=\"https://www.axios.com/2024/01/17/crispr-therapy-fda-expands\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">axios.com/2024/01/17/crispr-th</span><span class=\"invisible\">erapy-fda-expands</span></a></p>"
},
"attachment": [],
"tag": [
{
"type": "Hashtag",
"href": "https://toot.community/tags/crispr",
"name": "#crispr"
},
{
"type": "Hashtag",
"href": "https://toot.community/tags/genetherapy",
"name": "#genetherapy"
},
{
"type": "Hashtag",
"href": "https://toot.community/tags/healthcareinnovation",
"name": "#healthcareinnovation"
}
],
"replies": {
"id": "https://toot.community/users/CRISPR_News/statuses/111776001107602994/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://toot.community/users/CRISPR_News/statuses/111776001107602994/replies?only_other_accounts=true&page=true",
"partOf": "https://toot.community/users/CRISPR_News/statuses/111776001107602994/replies",
"items": []
}
},
"likes": {
"id": "https://toot.community/users/CRISPR_News/statuses/111776001107602994/likes",
"type": "Collection",
"totalItems": 1
},
"shares": {
"id": "https://toot.community/users/CRISPR_News/statuses/111776001107602994/shares",
"type": "Collection",
"totalItems": 0
}
}